金河生物(002688.SZ):擬與關聯方等設控股子公司 以實施鹽酸多西環素項目
格隆匯 3 月 2日丨金河生物(002688.SZ)公佈,公司擬與呼和浩特金益源管理諮詢企業(有限合夥)(“金益源”),內蒙古金河控股有限公司(“金河控股”),自然人劉雲龍、張鴻毅、蘇保仲等人共同投資5000萬元設立子公司內蒙古金河製藥科技有限公司(暫定名,最終以工商註冊登記為準,“金河製藥公司”),並由該控股子公司負責實施“鹽酸多西環素項目”。“鹽酸多西環素項目”預計總投資9091.86萬元。
新設公司金河製藥公司註冊資本5000萬元,公司以自有資金現金方式出資2550萬元持有51%的股權,金益源以自有資金現金方式出資650萬元持有13%的股權,金河控股以自有資金現金方式出資300萬元持有6%的股權,自然人劉雲龍、張鴻毅、蘇保仲等人以自有資金現金方式合計出資1500萬元持有30%的股權。
金河控股為公司董事長王東曉和其配偶路牡丹投資設立的公司,公司董事長王東曉為金河控股執行董事,金河控股與公司構成關聯關係。
公司副董事長李福忠擔任金益源執行事務合夥人,副董事長張興明、鄔瑞崗,董事、總經理謝昌賢,財務總監牛有山,董事、副總經理王志軍,副總經理雲喜報、劉迎春、菅明生,控股股東內蒙古金河建築安裝有限責任公司(“金河建安”)總經理焦秉柱為金益源的有限合夥人之一,金益源與公司構成關聯關系。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.